Create account
Log in
Clinical Guidelines
Home
About
About the clinical guidelines
Declaring and dealing with competing interests
Frequently asked questions
Guideline journal articles
CCA guidelines
Barrett's Oesophagus
Bowel cancer
Colorectal cancer
Surveillance colonoscopy
Endometrial cancer
Cervical cancer screening
Lung cancer
Lung cancer prevention & diagnosis
Lung cancer treatment
Prostate cancer
Advanced prostate cancer
PSA testing
Sarcoma
Skin cancer
Melanoma
Keratinocyte cancer (non-melanoma)
Pain management
Archive of CCA guidelines
COSA guidelines
Adolescents and Young Adult (AYA) guidelines
AYA early cancer detection
AYA psychosocial management
Cancer therapy medication safety
Gastroenteropancreatic neuroendocrine tumours
Head & neck cancer nutrition
Teleoncology
Hosted
Childhood Brain Tumour or Leukaemia
National Cancer Prevention Policy
Colorectal cancer
Introduction
Summary of recommendations
Plain-language summary
Colorectal cancer in Australia
Primary prevention
Introduction: primary prevention
Dietary and lifestyle strategies
Chemopreventive candidate agents
Population screening for colorectal cancer
Introduction: population screening for colorectal cancer
Evidence: Population screening for CRC
Evidence: Screening benefit (PSC1a)
Evidence: Screening test accuracy (PSC1b)
Evidence: Screening cost effectiveness (PSC1c)
Evidence: Screening age (PSC1d)
Evidence summary, recommendations and considerations
Discussion
The symptomatic patient
Introduction: the symptomatic patient
Signs & symptoms predictive of CRC
Optimal max time from referral to diagnosis and treatment
Risk and screening based on family history
Introduction: Risk and screening based on family history
Colorectal cancer risk according to family history (FHS2)
Screening strategies for people with a family history of colorectal cancer
High-risk familial syndromes
Introduction: high-risk familial syndromes
Familial adenomatous polyposis
MUTYH associated polyposis
Lynch syndrome
Peutz-Jeghers syndrome
Juvenile polyposis syndrome
Serrated polyposis syndrome
Supplement. State- and territory-based familial cancer registries
Imaging a patient with a diagnosis of CRC
Colon cancer
Rectal cancer
Addenda: rectal MRI cancer report
Pathology and staging
Introduction: pathology and staging
Development of post-surgical staging
Post-surgical staging following neoadjuvant therapy
Clinicopathological staging systems
Selection of staging system
Clinical input
Additional information on pathology reporting
Optimal molecular profiling of CRC
Preparation for surgery and perioperative optimisation
Introduction: preparation for surgery and perioperative optimisation
MDT meetings
Perioperative anaemia management
Thromboembolic prophylaxis
Nutritional interventions
Stomal therapy
Body temperature
Enhanced recovery after surgery
Mechanical bowel prep and antibiotic prophylaxis
Elective and emergency surgery for colon and rectal cancer
Optimal approach to elective resection for colon cancers (COL1-2a)
Optimal approach to elective resection for rectal cancers
Introduction: elective resection for rectal cancers
Optimal approach to elective resection for rectal cancers (COL1-2b)
Local versus radical resection for T1-T2 rectal tumours (REC3)
Emergency management of malignant large bowel obstruction (COLMNG5)
Peritonectomy with hyperthermic intraperitoneal chemotherapy (COLMNG3)
Adjuvant therapy for colon cancer
Introduction: adjuvant therapy for colon cancer
Adjuvant therapy for stage III colon
Adjuvant therapy for stage III colon
Adjuvant therapy for elderly stage III CRC (ADJ1)
Adjuvant therapy for stage II colon
Adjuvant therapy for stage II colon
Irinotecan and targeted agents (Stage II-III colon)
Discussion
Neoadjuvant & adjuvant therapy for rectal cancer
Introduction: neoadjuvant & adjuvant therapy for rectal cancer
Neoadjuvant therapy for rectal cancer
Neoadjuvant therapy for rectal cancer
Short course radiation treatment
Neoadjuvant long-course chemoradiation
'Watch and wait' approach after clinical complete response to neoadjuvant chemoradiation
Neoadjuvant chemotherapy regimen
Optimal timing surgery after neoadjuvant therapy
Adjuvant therapy for rectal cancer
Adjuvant therapy for rectal cancer
Postoperative chemotherapy
Postoperative radiation treatment
Discussion
Management resectable locally recurrent and metastatic disease
Introduction: management resectable locally recurrent and metastatic disease
Investigation of recurrent colorectal cancer
Management of recurrent, resectable CRC (MNG13)
Management of metastatic resectable CRC (MNG14)
Management non-resectable locally recurrent and metastatic disease
Introduction: management of non resectable recurrent metastatic CRC
Synchronous primary in metastatic CRC
Discussion
Role systemic therapies in non-resectable metastatic CRC
Introduction: role systemic therapies in non-resectable metastatic CRC
Molecular pathology and biomarkers for systemic therapy
Biological agents in first-line tx of metastatic CRC
Subsequent treatment & continuum-of-care model
Systemic second-line treatment
Systemic third-line treatment
Supportive care options
Follow-up after curative resection for CRC
Introduction: follow-up after curative resection for CRC
Rationale for follow-up
Optimal follow-up surveillance protocol (FUR1-2)
Health professionals performing follow-up & suggested schedule
Psychosocial care
Appendices
Guideline development process
Clinical question list
Journal articles
Technical report
Additional resources
Glossary and abbreviations
Working party members & contributors
Project team contributions
Conflict of interest register
View
Code
History
Refresh
What links here
Related changes
Special pages
Permanent link
Page information
Browse properties
Appendices
From Cancer Guidelines Wiki
Clinical practice guidelines for the prevention, early detection and management of colorectal cancer
>
Appendices
Jump to:
navigation
,
search
See:
Guideline development process
Clinical question list
Technical report
Glossary and abbreviations
Working party and sub-committee membership
Project team contributions
Conflict of interest register